The MDK Study: Using a Combination of Methadone-dexmedetomidine-ketamine for Postoperative Pain Control in Patients Undergoing Complex Spine Surgeries.

Dexmedetomidine, methadone and ketamine offer benefits when used as adjuncts in complex spine surgeries. Dexmedetomidine is reported to attenuate intraoperative stress responses without interfering with neuromonitoring while potentially improving postoperative pain control and reducing opioid consumption in complex spine surgery. Methadone use intraoperatively improves postoperative pain control and reduced opioid requirements following complex spine surgery. Consensus guidelines from the American Society of Regional Anesthesia and Pain Medicine, the American Academy of Pain Medicine, and the American Society of Anesthesiologists support the use of ketamine in acute pain management in surgeries like spine surgery. Perioperative ketamine use in spine surgery results in lower pain scores and reduced opioid utilization postoperatively. The use of dexmedetomidine, methadone and ketamine as adjuncts may improve postoperative pain control while reducing opioid requirements, lowering stress responses, and without significantly impacting neuromonitoring in complex spine surgery or increasing drug related adverse events.

• Methadone-dexmedetomidine-ketamine combination (Drug): Combination of Methadone-dexmedetomidine-ketamine administered during spine surgery for intra- and post-operative pain management.

Primary outcomes

• Effect of the MDK combination during surgery on postoperative opioid consumption [72 hours postoperatively]: Determine if use of dexmedetomidine, methadone, and ketamine given together intraoperatively has an effect on postoperative opioid consumption following complex spine surgery of 3 or more levels

Secondary outcomes

• Effect of MDK combination on overall postoperative pain scores. [72 hours after surgery]: Determine whether dexmedetomidine, methadone, and ketamine given together intraoperatively has an effect on overall postoperative pain scores following complex spine surgery compared to standard therapy. Pain scores using the visual analog scale, collected by nursing staff during hospital stay, will be used.
• Incidence of opioid-related adverse events [72 hours postoperatively]: Evaluate incidence of opioid related adverse events in patients treated with intraoperative combination of methadone, dexmedetomidine and ketamine compared to standard therapy. The number of adverse events per group will be collected.

Sex: All, ages: 18 Years to 79 Years

Inclusion criteria:

* Age 18-79 years of age
* Patients undergoing complex spine surgery, defined as 3 or more levels
* English-speaking
* Able to consent for themselves

Exclusion criteria:

* Patients who are unable to consent to study participation in English
* Patients who are unable to consent for themselves.
* Patients with prolonged QT syndrome
* Pregnancy

Additional screening measures:

* Preoperative ECG will be performed in preoperative holding as part of standard of care to assess for prolonged QTc prior to administration of methadone as part of SOC.
* Pregnancy test will be performed as part of SOC on the day of surgery.